Dernières nouvelles pour Ryde Group (AMEX:RYDE) Stock

Ryde Group

Ryde Group Ltd is a company providing a super mobility app offering ultimate convenience and reliability for their customers through multiple mobility tools that can be accessed and function seamlessly out of a single app. The company operates in the following segments such as being mobility where it provides on-demand and scheduled carpooling and ride-hailing services, matching riders to driver partners; and quick commerce where it provides on-demand, scheduled, and multi-stop parcel delivery services.

Ryde Group Ltd

Ryder System Inc

News

Jianzhi Education Technology Reports 1H: Revenue Decreased By 25.4% To RMB209.3M; Company Says It Is Rolling Out Several Key Initiatives Including Partnership With China's Top Telecom Operator To Boost B2B Operations Across Multiple Provinces

B of A Securities analyst Emma Xu maintains Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) with a Buy and raises the price target from $80.2 to $90.

Price Target

Analyst Ratings

FUTU

B of A Securities Maintains Buy on Futu Hldgs, Raises Price Target to $90

B of A Securities analyst Jason Kupferberg maintains Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) with a Buy and raises the price target from $365 to $388.

B of A Securities Maintains Buy on Accenture, Raises Price Target to $388

B of A Securities analyst Greg Harrison maintains Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) with a Buy and lowers the price target from $19 to $18.

TVTX

B of A Securities Maintains Buy on Travere Therapeutics, Lowers Price Target to $18

Insider Trades

ONCO

Altos Venture Reported A 32.5% Stake In Onconetix As Of September 24 In A 13D Filing On Thursday

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Armada Hoffler Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>)</h3>
<ul>
<li>On Sept. 26, Armada Hoffler Properties announced the pricing of an underwritten offering of 9 million shares of its stock for the total proceeds of approximately $94.5 million. The company's stock fell around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/AHH">52-week low of $9.81</a>.</li>
<li>RSI Value: 29.97</li>
<li>AHH Price Action: Shares of Armada Hoffler Properties fell 8.9% to close at $10.80 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1">latest AHH news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041219/image-218.png" alt="" class="wp-image-569278" style="width:686px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041219/image-218.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041219/image-218-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041219/image-218-768x717.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">La Rosa Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Thursday, La Rosa Holdings announced that it has entered into an amendment with its noteholder to restructure debt under three outstanding notes issued to the holder in February, April, and July 2024. As part of the amendment, the Company agreed to repay the holder $200,000 of the debt under the notes, and all principal and interest payments under the notes have been deferred until Feb. 1, 2025. The company's stock fell around 36% over the past month. It <a href="https://www.benzinga.com/quote/LRHC">has a 52-week low</a> of $0.52.</li>
<li>RSI Value: 29.83</li>
<li>LRHC Price Action: Shares of La Rosa gained 1% to close at $0.68 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1">trend in LRHC stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041345/image-219.png" alt="" class="wp-image-569280" style="width:718px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041345/image-219.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041345/image-219-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27041345/image-219-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Creative Media &amp; Community Trust Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCT#NASDAQ">CMCT</a>)</h3>
<ul>
<li>On Aug. 8, Creative Media posted better-than-expected quarterly results. &#8220;Our core FFO improved from the first quarter of 2024 due to improved net operating income across all of our real estate segments &#8211; multifamily, office and hotel,&#8221; said David Thompson, Chief Executive Officer of Creative Media &amp; Community Trust Corporation. &#8220;Our goal is to strengthen our balance sheet and improve our cash flow. In order to achieve this goal, we continue to actively evaluate asset sales and other ways to reduce both our recourse debt and overall debt.&#8221; The company's shares fell around 63% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CMCT">low of $0.68.</a></li>
<li>RSI Value: 14.80</li>
<li>CMCT Price Action: Shares of Creative Media &amp; Community Trust gained 3.9% to close at $0.72 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1">breakout in CMCT shares</a>.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41055695/wall-streets-most-accurate-analysts-spotlight-on-3-real-estate-stocks-delivering-high-dividend-yield">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields</a></li>
</ul>

Dividends

Pre-Market Outlook

Markets

Trading Ideas

CMCT

LRHC

Top 3 Real Estate Stocks That Are Preparing To Pump This Month

B of A Securities analyst Ruplu Bhattacharya maintains Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) with a Buy and raises the price target from $135 to $150.

B of A Securities Maintains Buy on Jabil, Raises Price Target to $150

TNXP

Tonix Pharmaceuticals Announces Issuance Of U.S. Patent Covering The Subcutaneous Delivery Of FDA-approved Zembrace Symtouch To Treat Migraines; New Patent Expected To Provide Market Exclusivity Into 2036

B of A Securities analyst Wamsi Mohan downgrades HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) from Buy to Neutral and maintains the price target from $37 to $37.

Downgrades

B of A Securities Downgrades HP to Neutral, Maintains Price Target to $37

JMP Securities analyst Steven Delaney maintains Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) with a Market Outperform and raises the price target from $16 to $16.5.

JMP Securities Maintains Market Outperform on Arbor Realty Trust, Raises Price Target to $16.5

Concord Medical Reports Financial Results For 1H: Revenues Fell 23.1% YoY To $30.1M

Baird analyst Tristan Gerra maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Outperform and lowers the price target from $172 to $150.

Baird Maintains Outperform on Micron Technology, Lowers Price Target to $150

The Company will also present additional results from the Phase&nbsp;2 BEACON study for LYR-220 in adult patients with CRS who have had prior ethmoid sinus surgery at the Annual Meeting of the American Academy of Otolaryngology&ndash;Head and Neck Surgery (AAO-HNS), taking place September 28 - October 1 in Miami.

LYRA

Lyra Therapeutics Announced That The Company Will Present Results From The Phase 3 ENLIGHTEN 1 Study For LYR-210, The Company's Lead Product Candidate For CRS

Baird analyst David Koning maintains Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) with a Neutral and raises the price target from $350 to $370.

Baird Maintains Neutral on Accenture, Raises Price Target to $370

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life. 
&nbsp;
COPD is the most prevalent chronic respiratory disease in China, and is a priority within the government&#39;s Healthy China 2030 public health plan.
Dupixent is now approved in four indications across respiratory and dermatological diseases in China.

REGN

Regeneron Pharmaceuticals And Sanofi Today Announced That  National Medical Products Administration In China Has Approved Dupixent (Dupilumab) As An Add-on Maintenance Treatment For Adults With Uncontrolled Chronic Obstructive Pulmonary Disease

Baird analyst Ben Kallo maintains HA Sustainable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NYSE">HASI</a>) with a Outperform and raises the price target from $36 to $47.

Hannon Armstrong Sustainable Infrastructure Capital

HASI

Baird Maintains Outperform on HA Sustainable, Raises Price Target to $47

Stephens &amp; Co. analyst Tommy Moll maintains ESCO Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESE#NYSE">ESE</a>) with a Overweight and raises the price target from $135 to $145.

Stephens & Co. Maintains Overweight on ESCO Technologies, Raises Price Target to $145

Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in&nbsp;Japan&nbsp;for the FARAPULSE&trade; Pulsed Field Ablation (PFA) System. The FARAPULSE PFA System, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal atrial fibrillation (AF), is a novel alternative to standard-of-care thermal ablation treatment.

Boston Scientific Receives Japanese Regulatory Approval For The FARAPULSE Pulsed Field Ablation System, Which Is Indicated For Isolation Of Pulmonary Veins In Treatment Of Paroxysmal Atrial Fibrillation

Baird analyst Ben Kallo maintains MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) with a Outperform and raises the price target from $20 to $25.

Baird Maintains Outperform on MP Materials, Raises Price Target to $25

Earnings

MITQ

Moving iMage Technologies Q4 Adj EPS $(0.04) Down From $(0.02) YoY, Sales $6.30M Up From $5.80M YoY

NOTV, BFRI and CPOP among pre-market losers

LIDR, INSG among major tech gainers; MVIS, DCBO among losers

MINM, LIDR among major tech gainers; SYTA, WDAY among losers

INSM, SINT and POAI are among mid-day movers

SOBR, AWIN among major tech gainers; SMXT, RYDE among losers

Ryde Group Limited Class A (RYDE) has released an update. Ryde Group Ltd, a leading Singapore-based mobility and quick commerce technology platform...

Ryde Group Expands into European Markets

Ryde Group Limited Class A (RYDE) has released an update. Ryde Group Ltd has entered into a consulting agreement to leverage strategic, advisory, a...

Ryde Group Ltd Signs Strategic Consulting Deal

Ryde: Overpriced Ride-Sharing Service Facing Intense Competition

Primega Group Holdings: Another Overvalued Chinese Micro-IPO Poised To Drop

Ryde prices $4.5M public offering

AIRJ

AWIN

BCAN

BFRI

CALT

CPOP

CXAI

DCBO

ESLT

FAAS

FROG

INSG

INSM

JBDI

LIDR

MINM

MRAI

MVIS

NEOV

NIVF

NOTV

OBLG

OKLO

OUST

PEGY

PGHL

POAI

RDZN

RYDE

SINT

SKYT

SMMT

SMXT

SNCR

SOBR

STSS

SYTA

TROO

UBXG

UEIC

VHAI

WDAY

Press Releases

Ryde Makes History as Singapore's First Ride-Hailing Startup to IPO on NYSE

Ryde Group Ltd Rings the New York Stock Exchange ("NYSE") Closing Bell on April 4, 2024

Ryde Supercharges Mobility with AI-Driven App Revamp

Ryde Group Ltd Listing on the Quotation Board of the Frankfurt and Stuttgart Stock Exchange

Ryde Group Ltd partners with Mobile-health Network Solutions

Ryde Unveils 7 Driver Commitments to Build a Fairer Platform

Ryde Takes Center Court with Tennis Star Sarah Pang Joining Ryde Empowers!

Ryde and Singlife Forge Strategic Partnership That Protects Passengers Beyond Rides

Ryde Group Ltd Addresses Share Price Volatility, Reaffirms Strong Business Fundamentals

Ryde Announces Pricing of $4.5 Million Public Offering

MNDR

Avis Budget Gr

Grab Holdings Limited - Class A Ordinary Shares

Grab Holdings

Hertz Global Holdings, Inc - Common Stock

Hertz Global Holdings

Lyft

Marti Technologies, Inc. Class A Ordinary Shares

Marti Techs

Swvl Hldgs

Uber Technologies

Zoomcar Holdings

Maxim Group

Comments

Ryde Group

Actualités

Dernières nouvelles pour Ryde Group (AMEX:RYDE) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL